Revance Therapeutics Cash from Financing (TTM) Analysis

Revance Therapeutics Inc (RVNC)

3.31 -0.98 (-22.84%) USD | NASDAQ | May 10, 16:00

3.31 0.00 (0.00%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2013. Upgrade now.

Date	Value
December 31, 2023	136.57M
September 30, 2023	132.02M
June 30, 2023	305.95M
March 31, 2023	229.65M
December 31, 2022	331.69M
September 30, 2022	338.27M
June 30, 2022	124.39M
March 31, 2022	106.14M
December 31, 2021	29.87M
September 30, 2021	96.79M
June 30, 2021	98.59M
March 31, 2021	96.18M
December 31, 2020	331.48M
September 30, 2020	378.99M
June 30, 2020	379.59M
March 31, 2020	379.14M
December 31, 2019	221.66M
September 30, 2019	106.99M
June 30, 2019	107.97M
March 31, 2019	110.87M
December 31, 2018	1.782M

Date	Value
September 30, 2018	160.28M
June 30, 2018	168.51M
March 31, 2018	168.72M
December 31, 2017	195.94M
September 30, 2017	36.61M
June 30, 2017	26.82M
March 31, 2017	22.96M
December 31, 2016	-2.642M
September 30, 2016	125.08M
June 30, 2016	135.09M
March 31, 2016	144.55M
December 31, 2015	142.59M
September 30, 2015	9.74M
June 30, 2015	-0.716M
March 31, 2015	120.57M
December 31, 2014	229.09M
September 30, 2014	254.68M
June 30, 2014	253.60M
March 31, 2014	130.29M
December 31, 2013	53.99M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

29.87M

Minimum

Dec 2021

379.59M

Maximum

Jun 2020

206.94M

Average

136.57M

Median

Dec 2023

Cash from Financing (TTM) Benchmarks